EMILY DAVIDSON: Open Payments
NPI 1548818198 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 10 payments from 8 companies in 2025. Trend: 2023 $169 · 2024 $507 · 2025 $285
Food & beverage: $170Education: $115
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $115 |
| Janssen Biotech, Inc. | 2 | $36 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $34 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: NERLYNX, Orserdu, LYNPARZA, ERLEADA, CALQUENCE, KISQALI, OPDIVO, DARZALEX.
Industry payments across NY — which companies pay providers there.
